Lesion-to-lesion Comparison of 68Ga-HA-DOTATATE, 18F-DOPA, and 18F-FDG PET/CT in the Evaluation of Metastatic Neuroendocrine Tumors
Condition(s):Neuroendocrine TumorsLast Updated:November 24, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Neuroendocrine TumorsLast Updated:November 24, 2023Recruiting
Condition(s):CancerLast Updated:May 16, 2019Terminated
Condition(s):Contrast Induced NephropathyLast Updated:October 12, 2009Unknown status
Condition(s):Type 2 Diabetes Mellitus; Diabetes Mellitus, Type 2Last Updated:March 19, 2012Completed
Condition(s):Renal Failure; Critically IllLast Updated:April 19, 2007Terminated
Condition(s):Insulin ResistanceLast Updated:August 24, 2010Completed
Condition(s):Chronic Stable Heart FailureLast Updated:April 22, 2008Completed
Condition(s):Chronic Stable Heart FailureLast Updated:April 22, 2008Completed
Condition(s):Actinic KeratosisLast Updated:May 1, 2019Unknown status
Condition(s):Cutaneous Common WartsLast Updated:September 14, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.